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The segmental premature aging disease Hutchinson-
Gilford Progeria (HGPS) is caused by a truncated and
farnesylated form of Lamin A. In a mouse model for
HGPS, a similar Lamin A variant causes the prolifera-
tive arrest and death of postnatal, but not embryonic,
fibroblasts. Arrest is due to an inability to produce
a functional extracellular matrix (ECM), because
growth on normal ECM rescues proliferation. The
defects are associated with inhibition of canonical
Wnt signaling, due to reduced nuclear localization
and transcriptional activity of Lef1, but not Tcf4, in
both mouse and human progeric cells. Defective
Wnt signaling, affecting ECM synthesis, may be crit-
ical to the etiology of HGPS because mice exhibit
skeletal defects and apoptosis in major blood
vessels proximal to the heart. These results establish
a functional link between the nuclear envelope/
lamina and the cell surface/ECM and may provide
insights into the role of Wnt signaling and the ECM
in aging.
INTRODUCTION
Aging is an inevitable consequence of life. With the identification
of specific genes affecting longevity, considerable interest has
arisen into understanding the molecular basis as to how organ-
isms age (Friedman and Johnson, 1988; Kennedy et al., 1995).
Among these genes is the mammalian Lamin A gene that
encodes the A-type lamins, intermediate filament proteins that
make up the bulk of the nuclear lamina (Gerace andBurke, 1988).DevelopmenThe A-type lamins have attracted much interest as at least
eight diseases, the laminopathies, result from mutations within
the LMNA gene (Burke and Stewart, 2006). Of these laminopa-
thies, themost striking is the segmental premature aging disease
Hutchinson-Gilford Progeria Syndrome (HGPS) (Gilford, 1904;
Hutchinson, 1886). Newborns with HGPS are seemingly normal.
By 12–18months, they exhibit persistent growth retardation, hair
loss, craniofacial abnormalities, osteolysis, and localized bone
demineralization (Merideth et al., 2008). The children develop
arteriosclerosis that is associated with loss of vascular smooth
muscle cells, degenerative aortic weakness, and mitral valve
disease. These conditions are inevitably fatal, due to stroke or
myocardial ischemia during the child’s mid-teens.
Lamin A protein undergoes posttranslational modification,
involving transient farnesylation of the cysteine at the C-terminal
CaaX motif, followed by removal of the farnesyl group and
18 amino acids by endoproteolytic cleavage by the protease
ZMPSTE24/FACE1 (Corrigan et al., 2005). These modifications
may be necessary for the localization of Lamin A protein to the
nuclear envelope (Lutz et al., 1992). Defective posttranslational
processing of Lamin A to its mature form results in about
three-quarters of the HGPS cases (Csoka et al., 2004a; De
Sandre-Giovannoli et al., 2003; Eriksson et al., 2003). The post-
translational defect is caused by a C-to-T nucleotide substitution
at position 1824 in the LMNA gene that creates a premature
splice donor site within exon 11. Inclusion of the novel splice
donor site results in a 50 amino acid in-frame deletion within
the C-terminal globular domain of Lamin A. The deletion elimi-
nates the second endoproteolytic cleavage site, resulting in
a truncated Lamin A protein (Progerin or LMNAD50) that remains
farnesylated, and is incorporated into the nuclear periphery
(Goldman et al., 2004).
Progerin results in abnormal nuclear morphologies, altered
chromatin organization, delayed mitosis, lamina thickening,
and growth arrest (Dechat et al., 2007; McClintock et al., 2006;tal Cell 19, 413–425, September 14, 2010 ª2010 Elsevier Inc. 413
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farnesyltransferase inhibitors (FTIs) rectifies the alterations in
nuclear morphology and improves, to some extent, the viability
of mouse lines retaining a farnesylated Lamin A protein (Capell
et al., 2005; Glynn andGlover, 2005).Whether all these patholog-
ical effects are solely due to persistent farnesylation or are com-
pounded by the deletion of the 50 amino acids is unclear (Yang
et al., 2008). Intriguingly, evidence has emerged suggesting
low levels of progerin may be expressed in fibroblasts from old
individuals and in late passage normal cells (McClintock et al.,
2007; Rodriguez et al., 2009; Scaffidi and Misteli, 2006). How
progerin causes HGPS and whether it contributes to the
‘‘normal’’ aging process is an area of intensive speculation.
Previously we described a mouse line carrying a mutated
Lmna gene (LmnaL530P/L530P, herein called D9Lmna) that
develops many of the pathologies associated with HGPS,
including craniofacial, dental, and skeletal abnormalities, loss
of subcutaneous fat, diminished postnatal growth, and early
death (Mounkes et al., 2003). The mutation results in the deletion
of exon 9 producing a truncated form of lamin A that we here
show remains farnesylated, demonstrating that this mouse line
provides a model to uncover the molecular etiology and
pathology of HGPS, which we here describe.
RESULTS
The Lmna D9 Mutation Results in a Truncated
yet Farnesylated Form of Lamin A
The LmnaD9mutation in our progeric mousemodel causes skip-
ping of exon 9, resulting in an in-frame deletion of 40 amino acids
from the Ig fold in the C-terminal globular domain of the lamin A
and C proteins. This results in an overall reduction of Lmna tran-
script levels and protein (Mounkes et al., 2003).
The consequences of the D9 deletion on the processing and
nuclear localization of lamin A protein were examined using an
HA-tagged LMNA-WT C-terminal globular domain (WT tail) and
HA-tagged LMNAD9 tail domain expressed in HeLa cells.
Human LMNA cDNA constructs were used as the mouse and
human LMNA genes show 98% homology. Restricting the use
to the tail domain overcomes potential complications arising
from interactions between themutant and full-length A-type lam-
ins in analyzing defects in posttranslational processing
(Hennekes and Nigg, 1994). The transfected cells were lysed in
TX-114 buffer and the phases separated. The majority of the
slower-migrating LMNA-WT tail was detected in the aqueous
(Aq), but not detergent phase (TX-114). Prelamin A (arrow) was
distinct from the mature lamin A (arrowhead). The LMNAD9
variant was detected as a single band (*) present in both the
aqueous and detergent phases, indicating that LMNAD9 does
not undergo efficient cleavage and about 50% of the protein
partitions to the detergent phase presumably due to the mature
form remaining farnesylated (Figure 1A).
We next examined whether LMNAD9 is farnesylated. In this
context, the CSIM variant refers to a wild-type CaaX motif in
normal prelamin A; in the SSIM variant, this cysteine is replaced
with a serine residue that cannot be farnesylated. HA-tagged full-
length CSIM and SSIM variants of the WT-LMNA and LMNAD9
were translated in reticulocyte lysates in the presence of either
35S-labeled cysteine andmethionine or 3H-labeledmevalonolac-414 Developmental Cell 19, 413–425, September 14, 2010 ª2010 Elstone (a precursor for farnesyl moieties). Autoradiographs of the
separated proteins reveal similar levels of protein translation as
observed by 35S labeling (Figure 1B, upper panel). Incorporation
of 3H-mevalonolactone into the lysates showed the CSIM and
not the SSIM variants were farnesylated (Figure 1B, lower panel).
To confirm this, HA-tagged full-length WT-LMNA and LMNAD9
were translated together with 20 mM of the farnesyltransferase
inhibitor (FTI) PB-43. In the presence of the FTI the 3H farnesyl
moiety was not incorporated in any of the lamins (Figure 1C).
A key issue in progeria is that proteolytic removal of the farne-
syl group is impaired. To determine if the LMNAD9 variant was
processed following farnesylation, HA- or MYC-tagged CSIM
or SSIM amino acid variants of full-length WT-LMNA and
LMNAD9 were separated by SDS-PAGE and immunoblotted
with anti-HA, MYC or prelamin A antibodies (Figure 1D). As de-
tected with anti-epitope tag antibodies (top panel) the
LMNAD9-CSIM remains similar in size to the SSIM variant, unlike
the WT-LMNA which is processed to mature lamin A, which
migrates faster than the SSIM variant. This was confirmed by
immunoblotting with prelamin A-specific antibodies detecting
significant amounts of all lamin variants, except the predomi-
nantly processed WT-LMNA-CSIM (lower panel). LMNAD9 is
therefore not efficiently cleaved into a mature form.
Last, we determined if LMNAD9 is targeted to the nuclear
envelope (NE). HA- or MYC- tagged full-length CSIM and SSIM
variants of WT-LMNA or LMNAD9 were transfected into Lmna
null MEFs and their localization assessed by immunofluores-
cence. The CSIM variant of LMNA-WT was predominantly de-
tected at the nuclear envelope, whereas the unfarnesylated
SSIM WT-LMNA was largely nucleoplasmic. Similar results
were observed for LMNAD9. Despite a lack of cleavage,
LMNAD9-CSIM is similar to farnesylated lamin A as it localizes
to the NE (Figure 1E).
LmnaD9 Inhibits Postnatal, but Not Embryonic,
Fibroblast Proliferation
HGPS children are seemingly normal at birth, with the first signs
of the disease appearing at 6–18 months. The delayed manifes-
tation of the disease is reflected by the proliferative characteris-
tics of progeric fibroblasts, in that they initially proliferate nor-
mally and then sometimes undergo a rapid decline in
proliferative capacity (Bridger and Kill, 2004). Similarly, the D9
mice are also overtly normal at birth, with weights identical to
those of their heterozygous and wild-type siblings. However,
the homozygotes show growth retardation within the first week
(Mounkes et al., 2003).
We investigated if proliferation of LMNAD9-expressing embry-
onic fibroblasts (MEFs) from E13 embryos was affected. Both
short-term and long-term (3T3) proliferation assays revealed
the D9MEFs proliferated at rates almost identical to those of
+/+MEFs, with only a slight reduction in total cell number being
observed in the long-term cultures (Figure 2A). This was
surprising as nuclear morphologies of the D9MEFs were
abnormal (Figure 2A, insert).
We then analyzed the growth of D9 postnatal fibroblasts
(MAFs), using primary fibroblast lines established from kidney,
skin, lung and skeletal muscle, of 2- to 3-week-old mice to deter-
mine if there was any topographical variation in proliferation
(Chang et al., 2002). In contrast to the D9MEFs, D9MAFs fromevier Inc.
Figure 1. D9LaminA Is Farnesylated and Not Processed to a Mature
Form
(A) WT LMNA tail partitions to the aqueous phase (Aq), not the detergent phase
(TX-114). PrelaminA (arrow) is distinct from mature LMNA (arrowhead). The
LMNAD9 tail is a single band (*) and partitions to both aqueous and detergent
phases.
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Developmenall tissues showed accelerated senescence and death
(Figure 2B) even though D9MEFs andMAFs expressed LMNAD9
at the same levels (see Figure S1 available online). Around p4-5
the D9MAFs started to detach from the dish (Figure 2C, right
panel) as they underwent apoptosis at twice the level (7%) of
wild-type MAFs (Figure 2D).
To verify the effect of the D9 mutation on cell proliferation and
to compare D9 with Progerin (D50), we introduced each mutant
form of LMNA, into primary Lmna null MAFs by retroviral vector-
mediated infection (Figure 2E) that resulted in equivalent levels of
expression of the different variants in the infected cells
(Figure 2F). Lmna/ MAFs show accelerated entry into senes-
cence, followed by the emergence of derivatives with enhanced
proliferative capability (Figure 2H). With the stable incorporation
of Lamin A into the lamina of Lmna/ MAFs, a regular nuclear
morphology is restored, (Figure 2G3) and the cells become sen-
escent, typical of wild-type cells (Figure 2H). In contrast, both D9
and D50, both of which were incorporated into the lamina, re-
sulted in abnormal nuclear morphologies and blebbing (Figures
2G1 and 2G2, respectively). Both mutant forms resulted in iden-
tical rates of accelerated proliferative arrest compared to cells
expressing WT-Lamin A (Figure 2H).LmnaD9 MAFs and Skeleton Show Altered Expression
of Extracellular Matrix and Cell Adhesion Genes
A possible cause of the inability of D9MAFs to proliferate and
their rapid death may have been genomic instability, because
human progeric lines show increased frequencies of chromo-
some breakage and defective DNA repair, particularly at telo-
meres (Liu et al., 2006). We were unable to find any evidence
for increased mitotic recombination, aneuploidy, chromosomal
breakage, or failure in DNA repair mechanisms as measured
by H2AX staining following UV irradiation in the D9MAFs (data
not shown). Telomerase activity was also unaffected (data not
shown). We therefore performed an Affymetrix microarray-
based gene expression analysis of passage 3 D9 and +/+MAFs
from 2- to 3-week-old siblings. Data were analyzed using the
Robust Multichip Algorithm (RMA) (Irizarry et al., 2003). Signifi-
cant changes in the expression of 194 transcripts, encoding
170 annotated genes (Table S1 available online; Figures S2A
and S2B) were identified (false discovery rate <0.001; fold
change >1.5). GO analysis of the transcript list, using the DAVID
bioinformatics resource (Thomas et al., 2003), revealed the most
significant molecular function grouping was for extracellular
matrix (p < 3.9E-10) (Tables S2A and S2B). We verified these
results by relative quantitation (RQ) PCR analysis on a subset
of 12 of the ECM/cell adhesion genes (Table S2B), confirming(B and C) HA-tagged full-length CSIM and SSIM variants of LMNA WT and D9
were translatedwith 35S-labeled cysteine andmethionine or 3H-labeled-meva-
lonolactone in the presence (C) or absence of 20 mM farnesyltransferase inhib-
itor PB-43.
(D) HA- or myc-tagged CSIM or SSIM variants of full-length human LMNA-WT
andD9were immunoblotted with anti-HA orMyc (top panel) or prelamin A anti-
bodies (lower panels). LMNAD9-CSIM is similar in size to the SSIM variant (top
right panel). CSIM WT-LMNA is processed and migrates faster than the SSIM
variant (top left panel).
(E) NE versus nucleoplasmic localization of CSIM and SSIM variants of LMNA-
WT and D9 was analyzed by immunofluorescence in Lmna/ MEFs.
tal Cell 19, 413–425, September 14, 2010 ª2010 Elsevier Inc. 415
Figure 2. D9 and D50 Result in Abnormal
Nuclear Morphologies and Accelerated
Proliferative Arrest
(A) WT (-) and D9 (C) MEF growth curves, with
nuclear morphology shown in the insets (DAPI
staining).
(B) WT (-) and D9 (C) MAF growth curves.
(C and D) Passage 4-5 WT (left panels) and D9
(right panels) MAFs assayed for morphology (C)
and apoptosis (D).
(E) Retroviral vectors for D9 or D50 HA-tagged
LMNA cDNAs. HA tag (black triangle) and dele-
tions (open triangles).
(F) Western analysis of retroviral protein produc-
tion. WT-LMNA is not HA tagged; all Lamins are
detected by the Jol2 monoclonal antibody
specific for hLMNA. The D50hLMNA band (arrow)
migrates just above a nonspecific band detected
in all samples by Jol2.
(G) Jol-2 immunostaining reveals nuclear
morphology in cells expressing Progerin/D50
(G1), D9 (G2), and Wt Lmna (G3).
(H) Lmna/ cells proliferate and immortalize.
Growth curves show the effect of reintroduction
of LMNA constructs.
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contrast, D9MEFs and +/+MEFs showed only minor differences
in gene expression (Figure 3A).
Many of the ECMgenes, with reduced expression, are compo-
nents of the cartilaginous and boney skeleton. Gene expression
comparisons from age-matched Wt and D9 mice in the calvaria,
tibias, and femurs revealed the majority of the same ECM genes
were significantly reduced in D9 skeletal tissues (Figure 3A).
GO analysis of biological processes revealed that
mesonephros, skeletal development, and cell adhesion were
significantly represented (Table S2C). We did not detect any
pathology associated with the kidneys; however, the skeletal
system showed reduced mineralization (Mounkes et al., 2003).
A high-resolution microCT comparison of skeletons of 2- to 3-
week-old D9 age-matched with Wt siblings (three of each geno-
type) revealed the mutants have reduced density in the calvaria416 Developmental Cell 19, 413–425, September 14, 2010 ª2010 Elsevier Inc.and long bones (Figures 3B and 3C,
respectively). Bone volume to total
volume ratio were significantly reduced
in the tibias and femurs (p < 0.04/0.01)
of the D9mice, as were trabecular thick-
nesses and number in the tibias and
femurs p < 0.001/0.04, respectively)
(Figure 3D). Calvarial, as well as tibial
and femoral stiffness were reduced,
shorter tibial tuberosity, evidence of rib
fractures, were also detected, all of
which indicated increased bone fragility.
A histopathological analysis and TRAP
staining for endosteal and periosteal
osteoclasts in the femurs and skulls
revealed no overt differences in cellular
organization or numbers of osteoclasts
between the wild-type and D9 skeletalsystems (data not shown) indicating that the reduction in
bone density was not associated with increased osteoclast
numbers.
Vascular Smooth Muscle of the Great Vessels Is Thinner
and Exhibits Extensive Apoptosis
The early to mid-teen death of progeric patients is due to cardio-
vascular defects resulting in a heart attack or stroke. A feature of
the pathology is loss of vascular smooth muscle cells (VSMC) in
the aorta, and other great vessels (Stehbens et al., 2001). Histo-
logical examination of the hearts and great vessels revealed that
the VSMC layer in the pulmonary artery showed thinning in six
homozygous D9 mice compared with age-matched (2) +/+ and
(4) +/ siblings at 2 weeks after birth. TUNEL analysis revealed
extensive apoptosis throughout the circumference of the
VSMC layer of the artery (Figure 3E). Only a few apoptotic cells
Figure 3. D9 Mice Show Reduced ECM Gene
Expression and Abnormal Skeletal and Vascular
Development
(A) Confirmation of the microarray analysis (Tables S1 and
S2A–S2C and Figures S2A and S2B) by RQ-PCR. Differ-
ences are expressed as the relative log ratio between
the D9 and Wt samples, with a 2-fold decrease being
equivalent to 0.301, 4-fold decrease 0.602, 5-fold
decrease 0.699, *p < 0.05, **p < 0.01, and ***p < 0.005
at the 95% confidence interval. Error bars are SEM.
(B–D) Calvarial (B) and long bone (C) mineral density, as
well as long bone volume and trabecular thickness and
number (D) in P14 WT and D9 sibling mice; *p < 0.05,
**p < 0.01, and ***p < 0.005 (three of each genotype).
(E) Apoptosis in pulmonary artery smooth muscle of P16
WT and D9 mice (TUNEL staining indicated by arrows).
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(data not shown).
Defective ECM Synthesis Results in Proliferative Arrest
and Is Not Rescued by FTI Treatment
To determine if the reduction in ECM protein expression resulted
in proliferative arrest and apoptosis of D9MAFs, we cultured
D9MAFs under continuous proliferation conditions on dishes
precoated with ECM deposited by wild-type fibroblasts.
Precoated dishes were prepared by culturing wild-type MAFs
to confluency and maintaining them for a week under contact-
mediated growth arrest. Under these conditions, the cells
deposit an ECM that remains on the dish after gentle lysis and
removal of the cells (Gospodarowicz et al., 1980). The resultsDevelopmental Cell 19, 413–4reveal that D9MAFs consistently grew to
passages comparable to wild-type cells when
maintained on the ECM derived from +/+MAFs
(Figure 4A). On wild-type ECM, D9MAFs
attained a higher cell density with fewer
detached cells (Figure 4B, right panel). We
also cultured the cells on dishes pretreated
with fibronectin, collagen, laminin, or thrombo-
spondin, all which showed reduced expression
in the array data. None of these factors
(including matrigel) were effective at rescuing
the proliferative failure of the D9MAFs, although
improved growth rates were noted with all
except fibronectin, with thrombospondin being
the most effective (Figure S3A), suggesting
that a combination of ECM factors is required
for MAF proliferation.
The farnesyl transferase inhibitor PB-43
improves the nuclear shapes of progeroid
mice and human fibroblasts in short term
culture (Toth et al., 2005). Treatment of the
D9MAFs with PB-43 did not rescue their prolif-
eration at different concentrations (100 nm to
5 mm). In fact growth of the D9, as well as +/+
MAFs, was severely inhibited by the FTI
(Figure S3B). We also observed similar negative
effects on +/+ and D9MAF proliferation by twoother FTIs, FTI-277 and FTI-276 (Calbiochem), at 1 and 3 mM
concentrations (data not shown).
Canonical Wnt Signaling Is Inhibited
by D9 and D50 LMNAs
To understand how a mutation in nuclear Lamin A results in
significant changes in the ECM, we analyzed which signaling
pathways were potentially affected. Analysis of the array data
revealed that components of Tgf-b superfamily (Bmp4 and 5,
Smad6, Ltbp-3), Wnt family (Ftz8, R-spondin, Dapper), and
Notch (notch3) signaling pathways were altered in their
expression.
Treatment of the D9MAFs with either Bmp4 or 5 only slightly
improved MAF viability and proliferation (data not shown).25, September 14, 2010 ª2010 Elsevier Inc. 417
Figure 4. D9MAF Growth Is Rescued by WT Extracellular Matrix
(A) Growth curves of WT MAFs and of D9MAFs in the presence or absence of
WT MAF ECM.
(B) Left panel D9MAFS at p4 with no ECM; right panel D9MAFs on ECM.
Growth of D9MAFs on specific ECM components or with FTIs is shown in
Figures S3A and S3B.
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Wnt signaling pathway, we performed TOPFlash luciferase
reporter assays for b-catenin-mediated transcriptional activity
(Morin et al., 1997). Plasmids containing cDNAs of wild-type
LMNA, LMNAD9, LMNAD50, their respective SSIM variants, as
well as native b-catenin and luciferase reporter vectors were
transfected into HEK293 cells with equivalent amounts of DNA
for each transfection (Yin et al., 2005). LMNAD9 significantly in-
hibited b-catenin-mediated Lef1-regulated transcription by
approximately 85% and LMNAD50 also inhibited b-catenin
activity, but to a lesser degree (50%) than D9, while the SSIM
version of LMNAD9 was only mildly inhibitory and the SSIM
version of LMNAD50 had no effect (Figure 5A).
We investigated whether the abundance of the b-catenin form
that preferentially binds to Lef1transcription factors was reduced
in HEK293 cells expressing LMNAD9 using a semiquantitative
specific TCF-GST pull-down assay (Gottardi and Gumbiner,
2004). LMNAD9-expressing cells showed a 70% reduction in
the nuclear levels of Lef1-binding to b-catenin compared with
controls, indicating that D9 reduced the levels of active Tcf/
Lef-b-catenin. LMNAD50, SSIM, and the +/+ forms had milder
inhibitory effects, suggesting that the deletions, as well as the
farnesylated status of the lamins contribute to the effect on
Wnt signaling (Figure 5B). Immunohistochemical staining of the
D9MAFs, +/+ cells and LMNAD9 transfected cells did not reveal418 Developmental Cell 19, 413–425, September 14, 2010 ª2010 Elsany obvious differences in b-catenin nuclear localization
between the +/+ and mutant cells (data not shown).Wnt, but Neither Tgf-b/nodal nor Notch Signaling,
Is Inhibited by LMNAD9in Xenopus Embryos
Injection of two- to four-cell stage Xenopus embryos with either
Xwnt3a or Xwnt8 mRNA results in the dorsalization and axis
duplication during larval stages. Xwnt3a mRNA alone or with
LMNA-WT mRNA resulted in approximately 75% of the larvae
becoming dorsalized and/or developing a duplicated axis, with
no larvae showing normal development (Figure 5C). In contrast,
coinjection with LMNAD9 mRNA suppressed Xwnt3a-mediated
duplication, resulting in only 25% of the larvae dorsalizing, with
50% of the larvae developing normally. Coinjection of the unfar-
nesylated LMNAD9-SSIMmRNA variant had no inhibitory effect
on axis duplication and dorsalization. LMNAD50 variants only
marginally inhibited axis duplication. Similar results were
obtained using Xwnt8 mRNA (data not shown).
We analyzed whether other signaling pathways, including the
Tgf-b/Nodal and Notch pathways were influenced by LMNAD9
mutation, as progerin may activate the Notch signaling pathway
in human mesenchymal stem cells (Scaffidi and Misteli, 2008).
Injection of Nodal mRNA into both ventral blastomeres at the
four-cell stage results in dorsalization of ventral explants (Jones
et al., 1995). This phenotype was not inhibited by coinjection of
the LMNAD9 mRNA (93 embryos tested). Similarly, injection of
the LMNAD9 mRNA into a two-cell stage blastomere did not
affect Notch-mediated effects on neurogenesis (49 embryos
tested) (Vernon et al., 2006).Impaired Wnt Signaling Is Due to Reduced Nuclear
Levels and Transcriptional Activity of Tcf/Lef1
Analysis of the differentially expressed genes in the D9MAFs
revealed that at least four—fibronectin, Bmp4, Col11A1,
R-spondin—are trancriptionally regulated by the Wnt pathway.
We focused on Col11A1 as the binding sites of the canonically
regulated transcription factor Lef1 were mapped to the promoter
region of the mouse Col11A1gene (Kahler et al., 2008). ChIP
analysis, using chromatin isolated from +/+MAFs confirmed
the binding to a region 541 to +269 around the transcriptional
start site. Binding of Lef1 to this region was reduced by 60% in
D9MAFs, and was enhanced by pretreatment of the cells with
the Gsk-3b inhibitor SB415286 (Figure 6A; Coghlan et al.,
2000). The reduction in Lef1 binding to the promoter was due
to a marked reduction (>90%) in Lef1 levels in the D9MAFs (Fig-
ure 6B), as measured by RT-PCR and was confirmed by western
analysis on nuclear extracts and immunofluorescence, revealing
reduced accumulation of Lef1 in the D9 nuclei (Figures 6C
and 6D). This was specific for Lef1, as Tcf4 expression was unaf-
fected (Figures 6C and 6D). Significantly Lef1 is not detectable
in +/+MEFs, whereas Tcf4 is expressed (Figure 6C), revealing
a difference in Lef1 expression between +/+MEFs and MAFs.
A comparison of two human progeric fibroblast lines
(AG11498, AG06297) with a fibroblast line from a normal parent
(AG03512), by western analysis of nuclear extracts and immuno-
fluorescence revealed that nuclear expression of LEF1, but not
TCF3/4, was also markedly reduced in the progeric fibroblasts
compared with normal fibroblasts (Figures 6E and 6F).evier Inc.
Figure 5. D9 and D50 Lamin Inhibit Wnt-
Mediated Transcription
(A) TOPflash/FOPflash luciferase reporter assays
with WT (BC), D9, D50 lamins, or their SSIM vari-
ants.
(B) Gst-Tcf pull-down of nuclear b-catenin levels.
(C) Injection of Xwnt3a mRNA into Xenopus
embryos, alone or in the presence of each
LMNA construct shown in (A) and (B). Lower
panel, western analysis shows amount of protein
derived from the different LMNAmRNAs injected.
Error bars are SEM.
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Proliferation by Inhibition of Gsk-3
Gsk-3a and b regulate the canonical Wnt signaling pathway by
phosphorylating and promoting the degradation of b-catenin.
Inhibition of Gsk-3b stabilizes b-catenin levels, resulting in
enhanced b-catenin-mediated transcriptional activity (Behrens
et al., 1996). We treated D9 and +/+MAFs with recombinant
Wnt3a protein or Wnt conditioned media but this did not improve
cell viability or proliferation. However, treatment with the
SB415286 inhibitor was effective. Inhibitor treatment stimulated
proliferation and viability of the D9MAFs in a dose responsive
manner, with 25 mM being the most effective at restoring the
survival and proliferation of the D9MAFs to a level comparable
to that of normal MAFs (Figure 7A), whereas the +/+MAFs were
only marginally stimulated by the inhibitor. At a dose of 10 mM,
SB-415286 also significantly improved proliferation of the human
progeric line AG06297 (Figure 7B).
DISCUSSION
Hutchinson-Gilford Progeria is caused bymutations in the LMNA
gene. Here, we have characterized the molecular and cellular
changes associated with the pathology of our previously re-
ported mouse model for HGPS (Mounkes et al., 2003). The D9
mutation results in the in-frame deletion of 40 amino acids
from the Ig fold domain of Lamin A. LaminAD9 protein remains
farnesylated, presumably because the deletion affects theDevelopmental Cell 19, 413–425, Seconformation of the Ig fold and hence
the overall structure of the C-terminal
globular domain. Disruption to the
domain may therefore prevent the endo-
protease, Zmpste24, recognizing the
second endoproteolytic site and effi-
ciently processing the removal of the far-
nesylated peptide. Our mouse model is
therefore a valid resource to determining
the pathological consequences of
a persistently farnesylated, truncated
Lamin A protein.
In many of the laminopathies the
pathology does not manifest until well
after birth, despite A-type lamins being
robustly expressed during embryogen-
esis (Rober et al., 1989; Stewart and
Burke, 1987). HGPS newborns areseemingly normal with the first clinical symptoms, becoming
apparent at 6–12 months (Merideth et al., 2008). We noted
that D9 newborn mice are normal with growth retardation
commencing during the first week and death ensuing at
3–4 weeks (Mounkes et al., 2003). In line with these effects
on in vivo growth, we find that D9MAF proliferation ceases,
with progerin also inhibiting MAF proliferation. In contrast,
D9MEFs, expressing identical LaminA levels, are unaffected,
consistent with normal fetal development. Although the
D9MEFs have abnormal nuclear morphologies, we were unable
to detect any significant differences in proliferation or gene
expression (apart from slightly altered levels in oncomodulin
and tenomodulin) between D9 and +/+MEFs. Fibroblast prolif-
eration, with respect to the D9mutation, is therefore profoundly
influenced by whether the cells are of embryonic or postnatal
origin.
As we found no evidence of gross genome instability (Dechat
et al., 2007; Liu et al., 2005) associated with the proliferative
decline in the D9MAFs (data not shown), we focused instead
on a defective ECM as the basis for impaired MAF proliferation,
consistent with previous reports, where ECM components were
the second largest group of genes misregulated in cultured
HGPS cells (Csoka et al., 2004b). A defective ECM is specific
to the D9mutation and not a consequence of reduced levels of
A-type lamins, as array analysis of Lmna null MAFs (Sullivan
et al., 1999) shows no significant alterations in the expression
of ECM genes (data not shown).ptember 14, 2010 ª2010 Elsevier Inc. 419
Figure 6. Lef1 Levels Are Reduced in D9 and
Progeric Cells
(A) ChIP analysis of Lef1 binding to the Col11A1 promoter
in WT and D9 MAFs, in the presence an absence of
pretreatment with the SB415286 Gsk-3b inhibitor (10 mm).
(B) RT-PCR detection of Lef1 mRNA in WT and D9MAFs.
(C) Western analysis of b-catenin, Lef1, and Tcf4 in WT
and D9MAFs and MEFs.
(D) Immunofluorescent detection of Lef1 and Tcf4 in WT
and D9MAF nuclei counterstained with DAPI.
(E) Lef1 and Tcf4 detection byWestern analysis of nuclear
extracts of fibroblast lines from two progeric patients
(Coriell #AG11498, AG06297).
(F) Immunofluorescence showing Lef1 in normal parental
(WT- AG03512) and progeric (AG11498) fibroblasts, nuclei
counterstained with DAPI.
Error bars are SEM.
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Defective Wnt Signaling in ProgeriaWhy, during the transition from embryonic to postnatal stages,
D9 fibroblast proliferation becomes dependent on an ECM is
unclear. One possibility is that changes in proliferation reflect
and depend on different functions (and composition) of the
ECMbetween embryogenesis and postnatal life. During embryo-
genesis, the ECM regulates cell migration, adhesion, differentia-
tion, and morphogenesis (Adams and Watt, 1993). Postnatally,
the ECM assumes a more structural role in maintaining tissue
integrity and homeostasis, particularly in tissues subjected to
extensive mechanical stress such as the skeletal and cardiovas-
cular systems (Brooke et al., 2003; Kjaer, 2004). In fibroblasts,
ECM composition and integrin expression changes both qualita-
tively and quantitatively during the transition from embryonic to
postnatal life (Chang et al., 2002). These changes have functional
consequences, as fetal and adult fibroblasts differ in their adhe-
sive and migratory parameters, and in their responses to growth
factors (Brink et al., 2005; Ellis and Schor, 1996).
The differences in MAF gene expression are reflected by
similar reductions for the same genes in the D9 skeletons. These420 Developmental Cell 19, 413–425, September 14, 2010 ª2010 Elsevier Inc.declines may underlie the skeletal pathologies
associated with HGPS and are consistent with
skeletal abnormalities in other mouse models
for progeria (Bergo et al., 2002; Varela et al.,
2005). Expression of many small leucine-rich
repeat glycoproteins (SLRPs), including
COMP, osteoglycin, osteomodulin, PRELP,
and fibromodulin, was reduced. Collagen fibril
assembly depends on these SLRPs, as well as
collagen XI (Kadler et al., 2008), which was
also reduced in the D9MAFs. Defective
synthesis of these proteins results in osteopore-
sis, osteoarthritis, and muscular dystrophy
(Ameye and Young, 2002; Aszodi et al., 2006).
Intriguingly, the progeroid variant of Ehlers-
Danlos syndrome (OMIM 130070), that shares
some of the pathologies found in HGPS, such
as short stature, osteopenia, skin defects, and
hair loss, is caused by defects in galactosyl-
transferase I, an enzyme essential for proteo-
glycan synthesis; mice doubly deficient in the
SLRPs, Decorin, and Biglycan also mimic thisphenotype (Corsi et al., 2002). ECM anomalies may also underlie
the increase in apoptosis in the VSMC in some of the great
vessels around the heart. Autopsies on HGPS patients noted
the marked loss of smooth muscle in the aortas and arteries
that is associated with disorganization of the surrounding
ECM, collagen fibrils, and basement membranes (Stehbens
et al., 2001), structures whose composition changes significantly
postnatally and are essential to maintaining vascular integrity
(Wagenseil and Mecham, 2009). Other genes, with reduced
expression, such as Notch3, are also of potential significance
to HGPS, as mutations predispose patients to ischemic stroke
(CADASIL) (Joutel et al., 1996).
Defective ECMSynthesis Is Associatedwith aReduction
in Wnt-Mediated Lef1 Transcription
A question raised by these findings is how does a disrupted
nuclear lamina result in alterations to cell membrane centered
functions, specifically production of a functional ECM? Impair-
ment of canonical Wnt signaling is an attractive explanation for
Δ
Δ
Δ μ
Δ μ
Δ μ
μ
A
B
Figure 7. Cell Proliferation Is Enhanced by Gsk-3b Inhibition
(A) Treatment of D9MAFs with the Gsk inhibitor SB415286 (25 mm) rescues
growth.
(B) Treatment of the progeric line AG06297 (10 mm SB415286) enhances
growth.
Error bars are SEM.
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Defective Wnt Signaling in Progeriathe progeric phenotype, as central to this pathway is b-catenin
which has dual functions in mediating cell-cell/matrix attach-
ment and as a transcriptional cofactor (Behrens et al., 1996).
Wnts regulate skeletogenesis and chondrogenesis (Chen et al.,
2008; Day et al., 2005), ECM composition, fibronectin expres-
sion, and also inhibit proapoptotic gene expression in fibroblasts
and osteoblasts (Almeida et al., 2005; Chen et al., 2007).
LmnaD9, and to a lesser extent D50, inhibit b-catenin tran-
scriptional activity. The SSIM variants, which cannot be farnesy-
lated, were less effective at inhibition. This indicates the dele-
tions, as well as persistent farnesylation, of D9 and D50,
contribute to transcriptional inhibition, consistent with mice
expressing an unfarnesylated form of D50 developing a slightly
milder pathology, compared with mice expressing the farnesy-
lated form of D50 (Yang et al., 2008). b-catenin levels were unaf-
fected; however, expression of Lef1 was greatly reduced. The
reduction correlated with diminished Lef1 binding to the
Col11a1 promoter, revealing a direct role of Lef1 in regulating
the expression of at least someof the ECMgenes in theD9MAFs.
The basis for how D9 and D50 affect the reduction in Lef1
levels remains obscure. A possibility is that nuclear import/reten-
tion of b-catenin is insufficient, because b-catenin regulates Lef1
expression (Hovanes et al., 2001). The Xenopus results indicate
that the Nodal-Smad and Notch signaling pathways are intactDevelopmenand global nuclear transport appears to be unaffected. The
translocation/retention of b-catenin and/or Lef1 into the nucleus
may be specifically impaired, consistent with the reduced levels
of b-catenin/Tcf/Lef complexes in the GST pull-down studies.
Nuclear import and retention of b-catenin is complex, involving
many factors (Willert and Jones, 2006). b-catenin does not
have a nuclear localization sequence and nuclear import may
be mediated by direct interactions with nuclear pore compo-
nents, independent of the importin/karyopherin pathway
(Fagotto et al., 1998). Progerin and D9 may interfere with nuclear
import/export by potentially disrupting nuclear pore function,
although it is not clear if progerin’s effect on nuclear transport
is specific or a consequence of generalized cell stress
(S. Adam, personal communication). Significantly, only Lef1
expression, but not the related factors Tcf4 or 3, was reduced,
suggesting that Lef1 may depend on some specific import/
retention process differing from the other Tcfs. It is also noted
that Lef1 is not expressed in +/+MEFs.MEFsmay therefore differ
from MAFs in their transcription factor requirements, and this
may be a basis for the differences in the ECM/proliferation
between D9MEFs andMAFs. Together, these results are consis-
tent with earlier studies where heterozygous Lef1 mice show
diminished bone mass and those null for Lef1 are postnatally
growth retarded, have defective hair and tooth formation, tissues
markedly affected in progeria (Noh et al., 2009; van Genderen
et al., 1994). In addition, in Zmpste24 null mice, where Lamin A
remains farnesylated, Wnt signaling is reduced in hair follicles
(Espada et al., 2008).
Besides D9 reducing Lef1 nuclear levels, D9 disrupts lamina
and NE organization. Within the NE is the LINC complex,
comprising KASH and SUN domain proteins, whose localization
to the NE, in part, depends on the lamins (Crisp et al., 2006; Starr
and Han, 2002). We now believe the nucleus does not float
around the cytoplasm like some unruly zeppelin, and is instead
physically tethered to the cytoskeleton by interactions between
the LINC complex and the three components of the cytoskeleton
(Crisp et al., 2006; Wilhelmsen et al., 2005). LINC disruption
correlates with a reduction in cytoplasmic stiffness, probably
due to changes in actin dynamics and/or organization and
a reduction in RhoA activity (Hale et al., 2008; Lammerding
et al., 2004). Such changes to cytoskeletal dynamics may affect
the synthesis and organization of the ECM, as well as Wnt
signaling, compounding the inhibition of Lef1 transcription
(Chapados et al., 2006; Chen et al., 2006).
In conclusion, our data reveal that progeric mutations within
the LMNA gene inhibit the Wnt pathway resulting in a reduction
in LEF1 function and defective ECM synthesis. Our results
provide support for the hypothesis, based on the few autopsies
from progeric patients, that progeria is a disease of the ECM and
connective tissue (Stehbens et al., 1999). This manifests by
abnormalities in skeletal homeostasis, dentition, connective
tissue, skin, and the vasculature (Merideth et al., 2008; Stehbens
et al., 1999). If these failures are due to defective Wnt signaling
and/or cytoskeletal-ECM function, then they suggest possible
new routes of intervention, which may help in treating the
disease. Finally, Wnt signaling and its role in aging and senes-
cence has attracted significant attention (Manolagas and
Almeida, 2007), although much of the evidence is seemingly
contradictory (DeCarolis et al., 2008). What Progeria tells ustal Cell 19, 413–425, September 14, 2010 ª2010 Elsevier Inc. 421
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Defective Wnt Signaling in Progeriaabout the normal aging process is also controversial (Ershler
et al., 2008). However, defective lamin processing may, at least,
underlie the normal aging processes in the vascular system
(Ragnauth et al., 2010).
EXPERIMENTAL PROCEDURES
Mouse Strains
The LmnaL530P/L530P (herein LmnaD9/D9) mice are previously described
(Mounkes et al., 2003). Care was provided in accordance to procedures in
the Guide for the Care and Use of Laboratory Animals (NIH Publication
No. 86-23, 1985).
Plasmids and Antibodies
LMNAD50, LMNAD9, CSIM, and SSIM variants and LMNA tail (r390-664) were
derived from HA- or Myc-tagged LMNA in pcDNA3.1 (Raharjo et al., 2001) by
PCR mutagenesis. Retroviral expression vectors for the WT or mutant LMNA
gene expression were derived from pBabe-puro. Vectors expressing GST,
Cad-GST, and TCF-GST were a gift from Dr. Cara Gottardi. All antibodies
used in this study are listed in Supplemental Experimental Procedures.
Primary Cell Lines, Proliferation, and Apoptosis Assays
PMEFs and PMAFs were established as described (Mounkes et al., 2003).
Cells were maintained in Dulbecco’s MEM (Chemicon)+10% fetal calf serum
(Invitrogen). Serum starvation medium contained 0.5% fetal calf serum.
Proliferation Assays
For single-passage short-term growth assays, cells were plated at 104/well in
12-well dishes and counted daily, in triplicate. Continuous passage assays
were performed according to the 3T3 protocol (Todaro and Green, 1963),
beginning one passage after derivation.
Apoptosis and TUNEL Assays
Apoptosis and TUNEL assays were performed using the Vybrant Apoptosis
Assay Kit #2 (Molecular Probes) and in situ cell death detection kit (Roche)
according to the manufacturer’s instructions. Cell sampling and data collec-
tion were by FACScan, B-D Immunocytometry Systems, and data analysis
was performed with Analysis Modfit software (Verity).
Transient Transfection and Luciferase Reporter Assays
HEK293 cells (1 3 105) were cotransfected using Fugene 6 (Roche) with
2 mg of Renilla luciferase internal standard pRLCMV (Upstate Biotechnology),
and/or 2 mg TOPFlash or FOPFlash firefly luciferase reporter plasmid (Prom-
ega) with 2 mg b-catenin (human full-length cDNA in pcDNA3.1) and/or with
wild-type or lamin mutants (full-length cDNAs described above). pcDNA3.1
(Invitrogen) plasmid was added to equalize the amounts of DNA transfected.
After 48 hr, luciferase activity was determined with the Dual-Luciferase assay
system (Promega) as described by the manufacturer. The renilla luciferase
vector, under control of a CMV promoter, was used to normalize transfection
efficiencies.
Xenopus Embryo Injections
PCR generated full-length mRNAs of the LMNA variants were cloned into the
pCS+ vector. Xenopus embryos were microinjected with mRNA derived from
NotI-linearized constructs transcribed with the mMessage mMachine kit (Am-
bion). LMNA RNAs (2.5 ng) were coinjected with 1.15 and 0.46 pg of Xwnt3a
and Xwnt8 RNA, respectively, into the two ventral blastomeres of four-cell
stage embryos and the embryos cultured to the larval stage before scoring.
In Vitro Translations
In vitro translations were performed as previously described (Crisp et al.,
2006). To detect farnesylation, 9mCi 3H-mevalonolactone (American Radiola-
beled Chemicals) was used in place of 35S-Translabel (MP Biolabs). The FTI
PB-43 was a gift from M. Gelb.
GST Pull-Down Assays
GST, cadherin-GST, or TCF–GST fusion proteins were expressed in Escheri-
chia coli and purified using glutathione agarose beads as described (Gottardi
and Gumbiner, 2004). GST fusion protein complexes were eluted from the422 Developmental Cell 19, 413–425, September 14, 2010 ª2010 Elsbeads and separated by SDS-PAGE, transferred to PVDFmembranes, blotted
with rabbit b-catenin antibody diluted 1:1000, and detected by chemilumines-
cence.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation assay was performed according to the manu-
facturer’s instructions using an EZ-Zyme Enzymatic Chromatin Prep Kit (Milli-
pore).
Microarray Analysis and Real-Time PCR
Total RNA was isolated from three independent triplicate cultures of wild-type
and LmnaD9 MAFs at the similar confluencies, after 72 hr of serum starvation.
Labeled samples were hybridized to Affymetrix Mouse Genome 430A
2.0 arrays. Data analysis was performed using the RMA normalization algo-
rithm of BRB-Array Tools version 3.7 (Biometrics Research Branch, NCI;
http://linus.nci.nih.gov/BRB-ArrayTools.html). Data sets containing significant
genes deregulated in LmnaD9were classified usingGeneOntology andDAVID
bioinformatics resources (Huang da et al., 2009). PCR quantification of mRNA
expression was performed using Applied Biosystems relative quantification
(RQ) protocols according to the manufacturer’s instructions. For detailed
procedures see Supplemental Experimental Procedures.
Microcomputed Tomography Scans
Lmna+/+ and LmnaD9 mice were examined by compact cone-beam tomog-
raphy (mCT40 scanner; Scanco Medical). Whole-body scans were performed
as previously described (Yang et al., 2008). mCT analysis of the axial and
limb bones was performed as previously described (Sawyer et al., 2009)
except scanning width was at 35 mm and CTan software used for the calcula-
tions. See Supplemental Experimental Procedures.
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